These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 23638530)

  • 1. Advances in the treatment of diabetic nephropathy.
    Cherney DZ
    Nephrol News Issues; 2013 Apr; 27(5):18, 33. PubMed ID: 23638530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antiproteinuric effect of antihypertensive agents in diabetic nephropathy.
    Gansevoort RT; Apperloo AJ; Heeg JE; de Jong PE; de Zeeuw D
    Arch Intern Med; 1992 Oct; 152(10):2137-9. PubMed ID: 1417388
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathophysiology of diabetic nephropathy: involvement of multifaceted signalling mechanism.
    Balakumar P; Arora MK; Reddy J; Anand-Srivastava MB
    J Cardiovasc Pharmacol; 2009 Aug; 54(2):129-38. PubMed ID: 19528810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Difficult therapy in patients with renal failure. What protects, what damages the kidneys?].
    Stiefelhagen P
    MMW Fortschr Med; 2005 Apr; 147(16):4-6. PubMed ID: 16392389
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of acarbose on blood glucose and proteinuria in patients with diabetic nephropathy.
    Tomino Y; Shirato I; Horikoshi S; Fukui M; Yamaguchi Y; Yokomatsu M; Ebihara I; Shimada N; Hishiki T; Hirano K; Rinno H; Shiota J; Kuramoto T
    Nephron; 2000 Jun; 85(2):190. PubMed ID: 10867532
    [No Abstract]   [Full Text] [Related]  

  • 6. Advances in the treatment of diabetic renal disease: focus on losartan.
    Rayner B
    Curr Med Res Opin; 2004 Mar; 20(3):333-40. PubMed ID: 15025842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic nephropathy and long-term treatment effects of rosiglitazone and enalapril in obese ZSF1 rats.
    Bilan VP; Salah EM; Bastacky S; Jones HB; Mayers RM; Zinker B; Poucher SM; Tofovic SP
    J Endocrinol; 2011 Sep; 210(3):293-308. PubMed ID: 21680617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating proteinuria in a diabetic patient despite hyperkalaemia due to hyporeninaemic hypoaldosteronism.
    van Nieuwkoop C; Ijpelaar DH; Bolk JH
    Neth J Med; 2007 Feb; 65(2):75-7. PubMed ID: 17379933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephron Protection in Diabetic Kidney Disease.
    Anders HJ; Davis JM; Thurau K
    N Engl J Med; 2016 Nov; 375(21):2096-2098. PubMed ID: 27959742
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic efficacy of different antihypertensive drugs in human diabetic nephropathy: an updated meta-analysis.
    Weidmann P; Schneider M; Böhlen L
    Nephrol Dial Transplant; 1995 Oct; 10 Suppl 9():39-45. PubMed ID: 8643207
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of different antihypertensive drugs on human diabetic proteinuria.
    Weidmann P; Boehlen LM; de Courten M
    Nephrol Dial Transplant; 1993; 8(7):582-4. PubMed ID: 8396739
    [No Abstract]   [Full Text] [Related]  

  • 12. Diabetic nephropathy.
    Castellino P; Giordano M; Tuttle KR
    Curr Ther Endocrinol Metab; 1997; 6():465-75. PubMed ID: 9174791
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of antihypertensive (captopril) therapy on proteinuria in diabetic nephropathy].
    Holländer E
    Orv Hetil; 1987 Apr; 128(17):893-5. PubMed ID: 3295665
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antihypertensive treatment in type 1 diabetes and diabetic nephropathy].
    Chantrel F; Kolb I; Bouiller M; Hannedouche T
    Nephrologie; 1999; 20(4):203-8. PubMed ID: 10480152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antihypertensive treatment in type II diabetes and diabetic nephropathy].
    Chantrel F; Bouiller M; Kolb I; Hannedouche T
    Nephrologie; 2000; 21(2):47-55. PubMed ID: 10798204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Considerations on the treatment of incipient diabetic nephropathy (lst of 2 parts)].
    Pérez Blanco FJ; Manzanares L; Moreno G; Cabello MJ
    An Med Interna; 1996 Apr; 13(4):193-7. PubMed ID: 8688481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure reduction is necessary for the reduction of proteinuria in diabetic nephropathy--comparison of different antihypertensive agents.
    Berger ED; Setzler BA; Werz U; Bader BD; Lipp HP; Risler T; Erley CM
    Nephrol Dial Transplant; 1999; 14 Suppl 4():28-9. PubMed ID: 10463204
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel biphenyl compound, VMNS2e, ameliorates streptozotocin-induced diabetic nephropathy in rats.
    Kurundkar SB; Sachan N; Kodam KM; Kulkarni VM; Bodhankar SL; D'Souza S; Vanage G; Ghole VS
    J Diabetes; 2010 Dec; 2(4):282-9. PubMed ID: 20923502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Microalbuminuria in diabetes: setting the points for treatment].
    Lehnert H; Klose S; Lobmann R; Zehnder D
    MMW Fortschr Med; 2006 May; 148(21):28-30, 33; quiz 34. PubMed ID: 16796185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of pioglitazone against cardiovascular injury are enhanced by combination with aliskiren in a rat model of diabetic nephropathy.
    Elrashidy RA; Asker ME; Mohamed HE
    J Pharm Pharmacol; 2012 Jun; 64(6):862-71. PubMed ID: 22571265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.